- Filed
- May 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2024 · Dec 31, 2024 | 8.4M sh |
| Shares Diluted restated | Q2 2024 · Dec 31, 2023 | 263.48K sh |
| Operating Cash Flow | Q2 2024 · Dec 31, 2024 | −$322.44K |
| Operating Cash Flow | Q2 2024 · Dec 31, 2023 | $1.38M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2024 | $132.24M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $100.67M |
| Stockholders Equity | Q2 2024 · Dec 31, 2024 | $225.11M |
| Stockholders Equity | Q2 2024 · Jun 30, 2024 | $162.36M |
| Current Liabilities | Q2 2024 · Dec 31, 2024 | $9.28M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $12.43M |
| Total Liabilities | Q2 2024 · Dec 31, 2024 | $10.97M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $15.56M |
| Current Assets | Q2 2024 · Dec 31, 2024 | $167.02M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $108.77M |
| Total Assets | Q2 2024 · Dec 31, 2024 | $236.06M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $178.72M |
| Eps Diluted | Q2 2024 · Dec 31, 2024 | −$0.95 |
| Eps Diluted restated | Q2 2024 · Dec 31, 2023 | −$19.62 |
| Eps Basic | Q2 2024 · Dec 31, 2024 | −$0.95 |
| Eps Basic restated | Q2 2024 · Dec 31, 2023 | −$19.62 |
| Sga Expense | Q2 2024 · Dec 31, 2024 | $2.33M |
| Sga Expense | Q2 2024 · Dec 31, 2023 | $2.79M |
| Net Income | Q2 2024 · Dec 31, 2024 | −$7.95M |
| Net Income | Q2 2024 · Dec 31, 2023 | −$5.19M |
| Operating Income | Q2 2024 · Dec 31, 2024 | −$5.22M |
| Operating Income | Q2 2024 · Dec 31, 2023 | −$4.31M |
| Gross Profit | Q2 2024 · Dec 31, 2024 | $5.86M |
| Gross Profit | Q2 2024 · Dec 31, 2023 | $6.58M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2024 | $20.51M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2023 | $20.37M |
| Short Term Debt | Q2 2024 · Jun 30, 2024 | $1.38M |